H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma

H.I.G. Capital is exploring options for its controlling stake in US-based Rising Pharmaceuticals, including a possible sale, according to people familiar with the matter.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.